Sign in to view content

Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial

Rajiv Anand, MD, FRCS, FASRS

Video
Published 2024

Related

Surgical Case Conference: Sengul Ozdek, MD, FEBO, FASRS
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2024
Safety and Activity of a Single, Intravitreal Injection of Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa (RP)
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2018
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Sai H Chavala, MD
On Demand Cases, Courses, and Papers
2021

Category: Hereditary Retinal Disease & Genetics

See more